Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)

OBJECTIVES: Although not licensed for acute bipolar depression, lamotrigine has evidence for efficacy in trials and its use is recommended in guidelines. So far there had been no prospective health economic evaluation of its use. METHODS: Cost‐utility analysis of the CEQUEL trial comparing quetiapin...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Judit, Geddes, John R., Gardiner, Alexandra, Rendell, Jennifer, Goodwin, Guy M., Mayer, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491973/
https://www.ncbi.nlm.nih.gov/pubmed/30375699
http://dx.doi.org/10.1111/bdi.12713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491973/
https://www.ncbi.nlm.nih.gov/pubmed/30375699
http://dx.doi.org/10.1111/bdi.12713

Ejemplares similares